MOSEIC Trademark

Trademark Overview


On Monday, November 17, 2025, a trademark application was filed for MOSEIC with the United States Patent and Trademark Office. The USPTO has given the MOSEIC trademark a serial number of 99500515. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 7, 2026. This trademark is owned by Axsome Therapeutics, Inc.. The MOSEIC trademark is filed in the Chemical Products category with the following description:

Bioavailability enhancing molecular complex as an intermediate product for use in the manufacture of pharmaceuticals for the treatment of migraines, neurological disorders and central nervous system disorders
moseic

General Information


Serial Number99500515
Word MarkMOSEIC
Filing DateMonday, November 17, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2026

Trademark Statements


Goods and ServicesBioavailability enhancing molecular complex as an intermediate product for use in the manufacture of pharmaceuticals for the treatment of migraines, neurological disorders and central nervous system disorders

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, February 13, 2026
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAxsome Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
US

Party NameAxsome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
US

Trademark Events


Event DateEvent Description
Monday, November 17, 2025NEW APPLICATION ENTERED
Monday, November 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 17, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 16, 2026ASSIGNED TO EXAMINER
Tuesday, January 20, 2026NON-FINAL ACTION WRITTEN
Tuesday, January 20, 2026NON-FINAL ACTION E-MAILED
Tuesday, January 20, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 13, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 1, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 7, 2026PUBLISHED FOR OPPOSITION
Tuesday, April 7, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED